Bio Essence (BIOE) Cash & Equivalents (2020 - 2026)

Bio Essence's Cash & Equivalents history runs 7 years deep, the most recent figure standing at $36177.0 for Q1 2026.

• In Q1 2026, Cash & Equivalents changed N/A year-over-year to $36177.0; the TTM figure through Mar 2026 stood at $36177.0 (changed N/A YoY), while the FY2024 annual figure was $1371.0, up 1102.63% from the prior year.
• Cash & Equivalents was $36177.0 for Q1 2026 at Bio Essence, up from $28741.0 in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $36177.0 in Q1 2026 to a low of $23.0 in Q1 2024.
• Historically, Cash & Equivalents has averaged $8119.3 across 5 years, with a median of $556.5 in 2022.
• The sharpest annual moves came in 2022 and 2024: Cash & Equivalents plunged 98.53% in 2022, then soared 33403.37% in 2024.
• A 5-year view of Cash & Equivalents shows it stood at $6262.0 in 2022, then sank by 98.18% to $114.0 in 2023, then soared by 1102.63% to $1371.0 in 2024, then soared by 1996.35% to $28741.0 in 2025, then rose by 25.87% to $36177.0 in 2026.
• The last three Cash & Equivalents figures came in at $36177.0 (Q1 2026), $28741.0 (Q3 2025), and $1371.0 (Q4 2024), per Business Quant data.